Conglomerates
Compare Stocks
2 / 10Stock Comparison
IRS vs BMA
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
IRS vs BMA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Conglomerates | Banks - Regional |
| Market Cap | $1.13B | $4.70B |
| Revenue (TTM) | $502.69B | $6.46T |
| Net Income (TTM) | $374.35B | $291.41B |
| Gross Margin | 61.2% | 68.3% |
| Operating Margin | 101.4% | 5.6% |
| Forward P/E | 0.0x | 0.0x |
| Total Debt | $455.48B | $465.41B |
| Cash & Equiv. | $36.66B | $2.78T |
IRS vs BMA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| IRSA Inversiones y … (IRS) | 100 | 449.4 | +349.4% |
| Banco Macro S.A. (BMA) | 100 | 436.3 | +336.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IRS vs BMA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IRS carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 7.1%, EPS growth 48.2%, 3Y rev CAGR 24.0%
- Lower volatility, beta 1.30, Low D/E 36.8%, current ratio 0.71x
- PEG 0.00 vs BMA's 0.00
BMA is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 1.76, yield 7.0%
- 48.5% 10Y total return vs IRS's 43.7%
- 7.0% yield, 1-year raise streak, vs IRS's 6.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.1% revenue growth vs BMA's -33.3% | |
| Value | PEG 0.00 vs 0.00 | |
| Quality / Margins | 74.5% margin vs BMA's 5.0% | |
| Stability / Safety | Beta 1.30 vs BMA's 1.76 | |
| Dividends | 7.0% yield, 1-year raise streak, vs IRS's 6.2% | |
| Momentum (1Y) | +11.6% vs BMA's -9.1% | |
| Efficiency (ROA) | 12.2% ROA vs BMA's 1.4%, ROIC 1.5% vs 5.5% |
IRS vs BMA — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
IRS leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
BMA is the larger business by revenue, generating $6.46T annually — 12.9x IRS's $502.7B. IRS is the more profitable business, keeping 74.5% of every revenue dollar as net income compared to BMA's 5.0%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $502.7B | $6.46T |
| EBITDAEarnings before interest/tax | $520.2B | $620.9B |
| Net IncomeAfter-tax profit | $374.4B | $291.4B |
| Free Cash FlowCash after capex | $289.8B | -$2.44T |
| Gross MarginGross profit ÷ Revenue | +61.2% | +68.3% |
| Operating MarginEBIT ÷ Revenue | +101.4% | +5.6% |
| Net MarginNet income ÷ Revenue | +74.5% | +5.0% |
| FCF MarginFCF ÷ Revenue | +57.6% | +12.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +0.9% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -4.8% | -136.4% |
Valuation Metrics
IRS leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 1.1x trailing earnings, IRS trades at a 95% valuation discount to BMA's 20.4x P/E. Adjusting for growth (PEG ratio), IRS offers better value at 0.01x vs BMA's 0.40x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.1B | $4.7B |
| Enterprise ValueMkt cap + debt − cash | $1.4B | $3.0B |
| Trailing P/EPrice ÷ TTM EPS | 1.10x | 20.42x |
| Forward P/EPrice ÷ next-FY EPS est. | 0.01x | 0.01x |
| PEG RatioP/E ÷ EPS growth rate | 0.01x | 0.40x |
| EV / EBITDAEnterprise value multiple | 47.21x | 8.47x |
| Price / SalesMarket cap ÷ Revenue | 3.21x | 1.01x |
| Price / BookPrice ÷ Book value/share | 1.26x | 1.64x |
| Price / FCFMarket cap ÷ FCF | 5.61x | 8.22x |
Profitability & Efficiency
BMA leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
IRS delivers a 25.5% return on equity — every $100 of shareholder capital generates $26 in annual profit, vs $6 for BMA. BMA carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to IRS's 0.37x. On the Piotroski fundamental quality scale (0–9), BMA scores 6/9 vs IRS's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +25.5% | +6.1% |
| ROA (TTM)Return on assets | +12.2% | +1.4% |
| ROICReturn on invested capital | +1.5% | +5.5% |
| ROCEReturn on capital employed | +1.6% | +5.5% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.37x | 0.11x |
| Net DebtTotal debt minus cash | $418.8B | -$2.31T |
| Cash & Equiv.Liquid assets | $36.7B | $2.78T |
| Total DebtShort + long-term debt | $455.5B | $465.4B |
| Interest CoverageEBIT ÷ Interest expense | 10.01x | 0.28x |
Total Returns (Dividends Reinvested)
BMA leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BMA five years ago would be worth $62,073 today (with dividends reinvested), compared to $47,054 for IRS. Over the past 12 months, IRS leads with a +11.6% total return vs BMA's -9.1%. The 3-year compound annual growth rate (CAGR) favors BMA at 69.4% vs IRS's 47.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -11.9% | -13.9% |
| 1-Year ReturnPast 12 months | +11.6% | -9.1% |
| 3-Year ReturnCumulative with dividends | +218.3% | +386.0% |
| 5-Year ReturnCumulative with dividends | +370.5% | +520.7% |
| 10-Year ReturnCumulative with dividends | +43.7% | +48.5% |
| CAGR (3Y)Annualised 3-year return | +47.1% | +69.4% |
Risk & Volatility
IRS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
IRS is the less volatile stock with a 1.30 beta — it tends to amplify market swings less than BMA's 1.76 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IRS currently trades 76.5% from its 52-week high vs BMA's 70.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.30x | 1.76x |
| 52-Week HighHighest price in past year | $19.14 | $106.15 |
| 52-Week LowLowest price in past year | $10.87 | $38.30 |
| % of 52W HighCurrent price vs 52-week peak | +76.5% | +70.5% |
| RSI (14)Momentum oscillator 0–100 | 50.1 | 53.1 |
| Avg Volume (50D)Average daily shares traded | 184K | 366K |
Analyst Outlook
BMA leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates IRS as "Buy" and BMA as "Buy". Consensus price targets imply 73.6% upside for BMA (target: $130) vs -11.3% for IRS (target: $13). For income investors, BMA offers the higher dividend yield at 7.02% vs IRS's 6.16%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $13.00 | $130.00 |
| # AnalystsCovering analysts | 2 | 14 |
| Dividend YieldAnnual dividend ÷ price | +6.2% | +7.0% |
| Dividend StreakConsecutive years of raises | 0 | 1 |
| Dividend / ShareAnnual DPS | $1253.80 | $7302.65 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.5% | 0.0% |
IRS leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). BMA leads in 3 (Profitability & Efficiency, Total Returns).
IRS vs BMA: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is IRS or BMA a better buy right now?
For growth investors, IRSA Inversiones y Representaciones Sociedad Anónima (IRS) is the stronger pick with 7.
1% revenue growth year-over-year, versus -33. 3% for Banco Macro S. A. (BMA). IRSA Inversiones y Representaciones Sociedad Anónima (IRS) offers the better valuation at 1. 1x trailing P/E (0. 0x forward), making it the more compelling value choice. Analysts rate IRSA Inversiones y Representaciones Sociedad Anónima (IRS) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IRS or BMA?
On trailing P/E, IRSA Inversiones y Representaciones Sociedad Anónima (IRS) is the cheapest at 1.
1x versus Banco Macro S. A. at 20. 4x. On forward P/E, Banco Macro S. A. is actually cheaper at 0. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: IRSA Inversiones y Representaciones Sociedad Anónima wins at 0. 00x versus Banco Macro S. A. 's 0. 00x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — IRS or BMA?
Over the past 5 years, Banco Macro S.
A. (BMA) delivered a total return of +520. 7%, compared to +370. 5% for IRSA Inversiones y Representaciones Sociedad Anónima (IRS). Over 10 years, the gap is even starker: BMA returned +48. 5% versus IRS's +43. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IRS or BMA?
By beta (market sensitivity over 5 years), IRSA Inversiones y Representaciones Sociedad Anónima (IRS) is the lower-risk stock at 1.
30β versus Banco Macro S. A. 's 1. 76β — meaning BMA is approximately 36% more volatile than IRS relative to the S&P 500. On balance sheet safety, Banco Macro S. A. (BMA) carries a lower debt/equity ratio of 11% versus 37% for IRSA Inversiones y Representaciones Sociedad Anónima — giving it more financial flexibility in a downturn.
05Which is growing faster — IRS or BMA?
By revenue growth (latest reported year), IRSA Inversiones y Representaciones Sociedad Anónima (IRS) is pulling ahead at 7.
1% versus -33. 3% for Banco Macro S. A. (BMA). On earnings-per-share growth, the picture is similar: IRSA Inversiones y Representaciones Sociedad Anónima grew EPS 48. 2% year-over-year, compared to -44. 6% for Banco Macro S. A.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IRS or BMA?
IRSA Inversiones y Representaciones Sociedad Anónima (IRS) is the more profitable company, earning 22.
3% net margin versus 5. 0% for Banco Macro S. A. — meaning it keeps 22. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IRS leads at 6. 6% versus 5. 6% for BMA. At the gross margin level — before operating expenses — BMA leads at 68. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IRS or BMA more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, IRSA Inversiones y Representaciones Sociedad Anónima (IRS) is the more undervalued stock at a PEG of 0. 00x versus Banco Macro S. A. 's 0. 00x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Banco Macro S. A. (BMA) trades at 0. 0x forward P/E versus 0. 0x for IRSA Inversiones y Representaciones Sociedad Anónima — 0. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BMA: 73. 6% to $130. 00.
08Which pays a better dividend — IRS or BMA?
All stocks in this comparison pay dividends.
Banco Macro S. A. (BMA) offers the highest yield at 7. 0%, versus 6. 2% for IRSA Inversiones y Representaciones Sociedad Anónima (IRS).
09Is IRS or BMA better for a retirement portfolio?
For long-horizon retirement investors, IRSA Inversiones y Representaciones Sociedad Anónima (IRS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
30), 6. 2% yield). Banco Macro S. A. (BMA) carries a higher beta of 1. 76 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IRS: +43. 7%, BMA: +48. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IRS and BMA?
These companies operate in different sectors (IRS (Industrials) and BMA (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: IRS is a small-cap deep-value stock; BMA is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.